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Evidence for a role of protein phosphatases 1 and 2A during early
nephrogenesis. Although most transcriptional events appear to be modu-
lated by reversible protein phosphorylation, little is known about the role
of this regulatory system during the development of mammalian organs.
Here we have studied the serine/threonine protein phosphatases (PP) 1
and 2A in the early embryonic rat kidney with regard to expression and
effects on growth and differentiation. All isoforms of PP-i and PP-2A were
ubiquitously expressed in 15-day embryonic (E15) kidneys (in situ hybrid-
ization studies). In contrast, mRNA for inhibitor-i (I-i), an endogenous
inhibitor of PP-i, was detected only in undifferentiated stem cells in the
outer cortical area. I-i is a novel marker for these cells. The abundance of
the PP-I protein, confirmed with immunoblotting, was high in the
embryonic kidney. In organ culture of E13 kidneys, okadaic acid (OA), an
exogenous inhibitor of PP-i and PP-2A, dose-dependently inhibited
growth and nephron formation (apparent half-maximal effect at 6 nM).
OA 10 n had little effect on the growth of cultured E15 kidneys, whereas
nephron formation was disturbed and morphological evidence of apopto-
sis was seen. In summary, this study points towards important roles for
protein phosphatases 1 and/or 2A in regulation of mitogenic activity in the
early embryonic kidney.
The mammalian kidney is derived from an embryonic structure
termed the metanephros. The undifferentiated metanephric mes-
enchyme is stimulated by the ureteric bud, an outgrowth from the
Wolffian duct, to condense and convert into epithelium, thus
giving rise to the glomeruli and the proximal and distal tubuli.
Various hormones, including IGF-I, IGF-II, TGFcw, TGFI3, EGF,
HGF and PDGF have been suggested to participate in the
sequence of inductive events that lead to the formation of
nephrons [1—5], but so far no single factor has been shown to
alone promote metanephric development in organ culture [6]. All
the above-mentioned hormonal factors will, via membrane recep-
tors, activate one or several intracellular signalling pathways
where the final step is a covalent modification of the target protein
via phosphorylation catalyzed by protein kinases or dephosphor-
ylation catalyzed by protein phosphatases. The effect on the target
protein is often preceded by a series of phosphorylation events
that involves both serine/threonine and tyrosine kinases and
phosphatases. A recent review article [71 drew attention to the
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central role that serine/threonine protein phosphatases play for
regulation of growth and differentiation. So far, few such studies
have been performed on mammalian tissue.
This study was performed to evaluate the role that intracellular
signalling via the serine/threonine protein phosphatases 1 and 2A
might play for the early development of the kidney. We have
determined the distribution of these phosphatases as well as of
inhibitor-i, an endogenous inhibitor of PP-i, in the early embry-
onic rat kidney. We have also examined the effect of okadaic acid,
an exogenous inhibitor of PP-i and -2A, on the growth and
differentiation of cultured embryonic rat kidneys.
Methods
Embryos from timed-pregnant Sprague-Dawley rats (Alab,
Sollentuna, Sweden) were used. Day 0 of pregnancy was deter-
mined by the detection of a vaginal plug. Before removal of the
embryos, the rats were sedated with an intraperitoneal injection of
either Inactin-Byk (Byk-Gulden, Konstan, Germany) 80 mg/i00 g
body wt, or sodium pentobarbital (Apoteksbolaget, Stockholm,
Sweden) 6 mg/100 g body wt.
Embryonic metanephric kidney rudiments were micro-surgi-
cally removed on days 13 or 15 of gestation (E13 or E15). They
were dissected free of surrounding tissue, placed on a Nuclepore
filter (Costar, Pleasanton, CA, USA) with a pore size of 0.05 j.rm,
and cultured as described [8, 9]. The medium was 1-MEM [10]
(Gibco, Paisley, Scotland, UK), supplemented with 10% fetal calf
serum and 1% L-glutamine. The cultures were kept for four days
in a humidified incubator at 37°C with a 95% air/5% CO2 mixture.
The medium was renewed at 48 hour intervals.
Histological sections, 6 jm thick, were cut from cultured kidney
explants that had been fixed in Bouin's solution, embedded in
paraffin and stained with hematoxylin-eosin.
For DNA quantification, metanephric explants were individu-
ally sonicated in a pH 7.4 salt buffer, containing 50 mM NaHPO4
(— 1 part 50 msi NaH2PO4 + 3 parts 50 mrvi Na2HPO4) and 2 M
NaC1. Total DNA was quantified with fluorometry as described
[11], using a TKO 100 DNA Fluorometer (Hoefer Scientific
Instruments, San Francisco, CA, USA) with calf thymus DNA as
standard. In all experiments, 8 to 10 kidneys from each category
were analyzed. Due to method sensitivity, the very small kidneys
belonging to the E13 category were pooled (2 kidneys/tube) and
analyzed together. These readings were accordingly divided by a
factor of 2. Readings were always compared with controls (% of
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Fig. 1. Dark field ( e) and bright field (b, V micrographs of in situ hybridizations for PP-i mRNAs in E15 kidneys. Signals for PP-la (a, b), PP-113
(c, d) and PP-ly (e, f) are all abundant and uniformly distributed throughout the fetal kidneys. Magnification is 50X. Bar = 200 /zm.
control). When readings from consecutive experiments were used
in the same graph, they were first standardized versus their
respective controls. Student's t-test was used for statistical analy-
sis, and P values < 0.05 were considered significant.
In situ hybridization
In situ hybridization was performed according to Ernfors et al
[12], with a few modifications. E15 rat kidneys were embedded in
Tissue-Tek (Miles Inc., Elkhart, IN, USA), frozen in liquid
nitrogen, cut in 10 sm sections on a cryostat (—20°C)and thawed
onto slides pre-treated with poly-L-lysine (Sigma Chemical Co.,
St. Louis, MO, USA) (50 mglml). The sections were fixed in 4%
paraformaldehyde, rinsed twice in phosphate-buffered saline,
dehydrated in a graded ethanol series including a five minute
incubation in chloroform. The following oligonucleotides were
used as hybridization probes: for rat protein phosphatase in
mRNA 5-GAG AGG CCA GTG TGA CCC ATG GCA GCA
TGA lIT CTG TAC A-3'; rat protein phosphatase 1f3 mRNA
5'-AGC ACC CAA TAC TCA GAG CTG ACA ATG TCC CAC
TGA CCA G-3'; rat protein phosphatase 1Yi mRNA 5'-TGT
GAG TTC TGT ATA AAC CGG TGG ACG GCA AGT TAG
TIC C-3'; rat protein phosphatase 2Aa mRNA 5'-CGC TAT
GCC AGA AAC TGG AliT Clii' GAC CAA CAA TGT CGC
GTC AGC-3'; rat protein phosphatase 2A/3 mRNA 5'-ACC CTF
TCC Clii' AAC CAG TCA CGA AGG ACG GCT ACT ACA
GCA GGC-3'; rat inhibitor-i mRNA 5'-CCA GTG TCC ATG
AAC TTC CAC ACT CAC TGG CGA TCC CCG GAT GTC-3'.
All the oligonucleotides are antisense and therefore complemen-
tary to the mRNAs for which they are specific. Using terminal
deoxyribonucleotidyl transferase (Scandinavian Diagnostic Ser-
vices, Falkenberg, Sweden), the probes were labeled at the 3' end
with [a-35S]dATP (Amersham, Little Chalfont, Buckinghamshire,
UK) to a specific activity of i0 cpm/mg. Hybridization was
performed in 50% formamide, 4x SSC (0.6 M sodium chloride,
0.06 M sodium citrate, pH 7.0), lx Denhardt's solution, 10%
dextran sulfate, 0.25 mg/ml yeast tRNA, 0.5 mg/ml sheared
salmon sperm DNA, 1% sarcosyl, 0.02 M Na2HPO4INaH2PO4
(pH 7.0), 0.05 M dithiothreiotol, using i0 cpm/ml for each probe.
The sections were hybridized at 42°C for 15 to 18 hours in a
humidified chamber with 0.1 ml of hybridization solution per
slide. They were subsequently washed 4 X 15 minutes at 56°C in
ix SSC. Controls for the specificity of the in situ labeling were
demonstrated by a concentration-dependent depletion of the
signal, provided by a 50- to 100-fold excess of unlabeled probe
added to the hybridization cocktail. Slides were dipped in Kodak
NTB-2 photo emulsion (diluted 1:1 in water), exposed for three to
b
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Fig. 2. Dark field (a, c) and bright field (b, d) micrographs of in situ hybridizations for PP-2A mRNAs in E15 kidneys. PP-2Aa (a, b) and PP-2A13 (c, d)
are abundantly expressed and uniformly distributed throughout the fetal kidneys. Magnification is 67x. Bar 200 m.
five weeks at 4°C, developed, fixed and counterstained with cresyl
violet. Photographs were taken under bright field and dark field
illumination, using Kodak T-MAX 400 film.
Immunoblotting
Adult (40-day-old) renal medulla, E13 and E15 metanephric
mesenchymes were sonicated in 1% sodium dodecyl sulfate with a
Branson Sonifier B-12 (Branson Power Company, Danbury, CT,
USA). Total protein was determined with a protein assay (Bio-
Rad, Hercules, CA, USA), using bovine serum albumin as a
standard. Protein (4 mg per lane) was loaded on a 12% acrylamide
mini-gel, separated with electrophoresis and transferred electro-
phoretically to nitrocellulose. Rabbit antisera raised against syn-
thetic peptides from the C-terminals of PP-la and PP-1y1 cata-
lytic subunits were used to identify protein phosphatase irs and y
(apparent molecular wt 37 kDa), respectively. The specificity of
these antibodies has previously been demonstrated [da Cruz e
Silva EF and Greengard P, unpublished observations; 13]. Detec-
tion of the bound primary antibody was performed with an
alkaline phosphatase system (Promega, Madison, WN, USA).
Drugs used
In some of the protocols, the kidneys were cultured in the
presence of okadaic acid (Calbiochem, La Jolla, CA, USA), an
inhibitor of PP-i and PP-2A [141. Okadaic acid inhibits purified
PP-la PP-ly
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Fig. 3. Immunoblot for PP-i catalytic subunits a and y in E13 and E15
kidneys ("13" and "15", respectively), compared with adult renal medulla
('M"). Both isoforms are detected as bands corresponding to an apparent
molecular wt of approximately 37 kDa. Note that the abundance of both
isoforms increases with age and that adult levels for PP-la appear to be
reached at the E15 stage.
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Fig. 4. Darkfield ( c) and corresponding bright field (b, d) micrographs of in Situ hybridizations for Inhibitor-i (I-i) mRNA in E15 kidney. a, b. I-i labeling
is detected almost exclusively in the outermost part of the fetal kidney, in mesenchymal cells with no morphological signs of induction. c, d. Detail
magnification reveals that ureteric epithelium and mesenchymal condensations is almost devoid of signal. Note that the strongest expression is seen in
cells lying on the cortical side of the ureteric bud (the tips of which are marked with arrows), where no induction takes place. An adjacent S-shaped
body is also seen (open arrow). Magnification is 67x (a, c) and 270X (b, d), respectively. Bar = 100 sum.
PP-2A about 100-fold more potently than it inhibits purified PP-i
[14—16]. Okadaic acid was dissolved in dimethyl sulphoxide
(DMSO) (Fluka Chemie AG, Buchs, Switzerland) and added to
the medium at onset of culture. Equivalent amounts of DMSO
were added to the controls.
Results
The catalytic subunit of PP-I is encoded by three different genes
(a, /3 and -y) and that of PP-2A by at least two different genes (a
and f3). The expression of PP-i and PP-2A mRNA in the E15
kidney (which contains uninduced mesenchymal cells as well as
S-shaped bodies and tubules) was studied with in situ hybridiza-
tion technique. Strong signals for the mRNA for both phospha-
tases were detected in uninduced and condensing mesenchyme,
comma-shaped and S-shaped bodies, ureteric bud and stroma.
The intensity was approximately the same in all cell types (Figs. 1
and 2).
The presence of the PP-i protein in E13, E15 and adult kidneys
was confirmed with immunoblotting using antibodies raised
against PP-la and Yi PP-la and 'y1 were both present in the
embryonic kidneys. The abundance was higher in Ei5 than in El3
kidneys. The abundance of PP-la was similar in Ei5 kidneys and
adult medulla, whereas the abundance of PP-iy1 appeared to be
slightly lower in Ei5 kidneys than in adult medulla (Fig. 3). In the
adult kidney, tissue from the outer medulla was used, since this
tissue has a very high content of PP-i.
Inhibitor-i (I-i) is an endogenous inhibitor of PP-i. In situ
hybridization for I-i mRNA was performed in E15 kidneys. In
contrast to the ubiquitous localization of PP-i and PP-2A, mRNA
for I-i was only detected in mesenchymal cells in the outer cortical
area of the developing kidney (Fig. 4). These cells have not yet
been reached by the ureteric bud and have thus remained
metanephric mesenchymal stem cells.
Organ culture of embryonic kidneys is an excellent and well-
defined model system for the in vitro study of early mesenchymal
differentiation [8, 17], closely resembling the development in vivo.
During the first 24 hours of culture, the early embryonic kidneys
do not grow much, presumably because they need to adapt to the
culture situation. Therefore, to evaluate the functional role of
PP-i and PP-2A during early kidney development, okadaic acid
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Fig. 5. Hematoxylin-eosin-stained sections of E13 kidneys after four days of culture with or without OA. a, Control; b, OA 3 nt; c, OA 6 nM; d, OA 10
flM. Morphogenesis and growth are normal in a and b, but are severely disturbed in c and d. Magnification is 67x (a, b) and 135x (c, d), respectively.Bar = 100 m.
(OA), a potent inhibitor of both phosphatases, was added to
organ cultures of E13 and E15 kidneys during four days of culture.
After two days, the okadaic acid-treated kidneys started to be
distinguishable from control kidneys. After four days, OA was
found to dose-dependently inhibit growth of the E13 kidneys.
Apparent half-maximal effect was reached at 6 nM and full growth
inhibition at 10 nM. OA 6 n also caused a marked disturbance of
tubule formation (Fig. 5). To evaluate whether the observed
growth inhibition was due to a true reduction in cell number
rather than a decrease in cell size, we quantified the DNA content
per cultured E13 kidney. DNA analysis revealed a markedly lower
total DNA content, with half-maximal effect at 6 flM and full effect
at 10 nM OA (Fig. 6). In this assay, OA in doses of 1 to 10 nM
neither affected the explant size nor the amount of DNA (Fig. 6)
of E15 kidneys cultured for four days. Yet, OA 10 nM severely
affected nephron formation. The central parts of OA-treated E15
kidneys had a larger fraction of stromal tissue and fewer epithelial
structures than the controls. They also displayed a higher degree
of condensed or pycnotic nuclei in the mesenchymal parts (Fig.
7d), suggesting apoptosis [18, 19]. The tubules, comma- and
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Fig. 6. Total DNA content (expressed as % of control) in E13 (0) and E15(•) kidneys cultured for four days in the presence of OA. Values are mean
plus or minus SE. For each category, 8 to 10 kidneys were analyzed. The
6 and 10 flM values for E13 kidneys are highly significant (P < 0.01). In the
E15 category, there is a slight, but not significant, increase of DNA at 6 nM.
S-shaped structures were poorly organized (Fig. 7). OA in doses
higher than 100 flM completely inhibited growth of E15 kidneys
(data not shown).
Discussion
This study establishes vital roles for the serine-threonine pro-
tein phosphatases 1 and/or 2A during early kidney development.
The mRNA of these phosphatases was well expressed in all cell
types. Low doses of okadaic acid inhibited growth in the early
(E13) embryonic kidney and caused disturbances of nephron
formation in E15 kidneys.
In a previous study the distribution of PP-i mRNA was
examined with in situ hybridization technique in the adult kidney
and was found to be differentially distributed [Li et a!, manuscript
in preparation; 20]. The signal for all PP-i isoforms was very low
in the Si and S2 proximal tubular segments, but strong in the S3
proximal tubular segments located in the inner cortex and in the
cells of the thick ascending limb of Henle. Labeling of all isoforms
was also strong in the ureter, the former inducer. In contrast, in
the embryonic kidney the mRNAs for PP-ia, 3 and y were evenly
distributed in all cells. This developmental change in the distri-
bution suggests that PP-i plays a different role in the developing
and the mature kidney. The appearance of the mRNA for PP-i
isoforms in all cells in the embryonic kidney further indicates that
these enzymes may be of importance both for induction and for
early differentiation and growth. In line with this, in ongoing
studies we (JS) have observed that the abundance of PP-2A
mRNA is much lower in the adult than in the embryonic kidney.
Both the a and the y isoform of PP-i appeared to increase in
abundance from E13 to E15 kidneys. As a reference tissue, the
outer medulla from rat kidney was used. In this tissue the
abundance of PP-ia and Yi is comparable to that of the brain and
much higher than in most other tissues. The finding that the
abundance of PP-ia and Yi was similar in Ei5 kidney and in the
outer medulla of the adult kidney therefore indicates a very high
content of these phosphatases in the embryonic kidney.
In rats, the Ei3 kidney represents the earliest developmental
state of the metanephric kidney. At this stage only the first
branching of the ureter has occurred. These embryonic kidneys
were extremely sensitive to the growth retarding effect of okadaic
acid. OA inhibits purified PP-i and -2A with IC50 values of 15 to
200 flM and 0,5—1,0 nM, respectively [15]. Since in Ei3 kidneys half
maximal effect on DNA content was observed with less than 10 flM
of OA, it is possible that PP-2A might be of particular importance
for the growth of the early embryonic kidney. In Ei5 kidney,
somewhat higher doses were required to inhibit growth. OA 10 nM
did, however, profoundly affect the structural development of the
Ei5 kidney. Of particular interest was the increased appearance
of pycnotic nuclei in the OA-treated kidney, indicating that PP-i
and/or -2A might be involved in the control of apoptosis. This
does not necessarily imply a specific role for protein phosphatases
in apoptosis. There is ample evidence from studies of cell extracts,
cell lines and oocytes that dephosphorylation induced by PP-i and
PP-2A can have significant effects on several steps in the cell cycle
[21—26]. Both PP-i and PP-2A appear to be involved in the
regulation of the activity of the maturation-promoting factor
(MPF) [27, 281. They can also regulate the activity of the
MAP-ERK kinases [29, 30], important intermediary messengers
for most mitogens.
A striking finding in this study was the expression of inhibitor-i
exclusively in the mesenchymal stem cells. Inhibitor-i, which can
be activated by PKA-dependent phosphorylation, is an endoge-
nous inhibitor of PP-i. This finding indicates that the activity of
PP-i in the mesenchymal stem cells will, at certain stages, be
down-regulated by a signalling system where cAMP is a messen-
ger. The localization of inhibitor-i in mesenchymal stem cells is
interesting from another aspect, as it provides us with a novel
marker for these cells. A variety of markers for the different stages
of epithelial and stromal differentiation have been identified [31],
but to our knowledge inhibitor-i is the first described marker for
the stem cells.
In summary, this study points towards important roles for the
serine/threonine protein phosphatases 1 and/or 2A during regu-
lation of the mitogenic activity in the early embryonic kidney. In
these kidneys, PP-i and/or -2A appear to promote growth and
might control apoptosis. The net activity of the proteins that
modulate the cell cycle will to a large extent depend on the
proportion of the phosphorylated and dephosphorylated state of
these proteins, which in turn depends on the activity of protein
kinases and phosphatases. Further studies on PP-i and -2A
activity and their relationship to serine/threonine kinase activity
might therefore provide a better understanding of the mecha-
nisms that lead to kidney deformities and the formation of kidney
tumors.
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Fig. 7. Hematoxylin-eosin-stained sections of E15 kidneys after four days of culture with or without OA. a, Control; b, OA 6 nM; c,OA 10 nM; d, OA 10
flM, detail magnification. Growth is similar in control kidneys and OA-treated kidneys. However, at 10 nM, morphogenesis is disturbed; ureteric
branching and tubular epithelium are more sparse, and instead an increased amount of stromal tissue can be seen. Note groups of pycnotic and
fragmented nuclei in the mesenchyme (arrows). The tip of a ureteric bud (same in c and d) is marked with an open arrow. Magnification is 67X (a, b,
c) and 270x (d), respectively. Bar 100 rm.
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